Rivulet Entertainment (RIVF) 10-K 30 Mar 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Mar. 17, 2020	Jun. 30, 2019
Details
Registrant CIK	0001342936
Fiscal Year End	--12-31
Registrant Name	ADVANCED VOICE RECOGNITION SYSTEMS, INC.
SEC Form	10-K
Period End date	Dec. 31, 2019
Trading Symbol	AVOI
Trading Exchange	NONE
Tax Identification Number (TIN)	98-0511932
Number of common stock shares outstanding		279,720,268
Public Float			$ 3,469,084
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Voluntary filer	No
Well-known Seasoned Issuer	No
Shell Company	true
Small Business	true
Emerging Growth Company	true
Ex Transition Period	false
Entity File Number	000-52390
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	7659 E. Wood Drive
Entity Address, City or Town	Scottsdale
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85260
City Area Code	480
Local Phone Number	704-4183
Title of 12(b) Security	Common Stock par value $0.001 per share
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Document Annual Report	true
Document Transition Report	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 6,241	$ 17,583
Total Current Assets	6,241	17,583
Non-Current Assets
Patent, net	28,687	43,390
Total Non-Current Assets	28,687	43,390
Total Assets	34,928	60,973
Current Liabilities
Accounts payable	46,083	49,385
Payroll	162,382	162,382
Note Payable Meyer & Assoc.	0	19,100
Note Payable AIP	19,935	19,935
Note Payable Related Party	0	6,500
Accrued Interest	10,222	8,065
Total Current Liabilities	238,622	265,367
Total Liabilities	238,622	265,367
Stockholders' Deficit
Common stock	278,220	267,020
Additional paid-in capital	7,936,600	7,878,798
Accumulated Deficit	(8,418,514)	(8,350,212)
Total Stockholders' Deficit	(203,694)	(204,394)
Total Liabilities and Stockholders' Deficit	$ 34,928	$ 60,973

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Details
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	547,500,000	547,500,000
Common Stock, Shares, Issued	278,220,268	267,020,268

Consolidated Statement of Opera

Consolidated Statement of Operations - USD ($)		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018
Details
Sales		$ 0	$ 0
Cost of goods sold		0	0
Gross profit		0	0
Operating expenses:
Compensation		4,916	1,444
Professional fees		28,014	26,357
Office		29,701	27,006
Travel		1,614	773
Other		2,403	2,758
Total operating expenses		66,648	58,338
Loss from operations		(66,648)	(58,338)
Other income and (expense):
Interest expense		(5,488)	(8,962)
Gain (Loss) on Extinguishment of Debt		3,834	0
Net other expense		(1,654)	(8,962)
Loss before income taxes		(68,302)	(67,300)
Provision for income taxes		0	0
Net Loss		$ (68,302)	$ (67,300)
Basic and diluted loss per common share*	[1]	$ 0	$ 0
Weighted average number of common shares		273,368,169	254,477,727
[1]	*less than $0.01 per share

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flows from Operating Activities:
Net loss	$ (68,302)	$ (67,300)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and depreciation	14,703	14,390
Gain from settlement	(3,834)	0
Changes in operating liabilities:
Accounts payable and accrued liabilities	1,189	(22,649)
Net cash used in operating activities	(56,244)	(75,559)
Cash Flows from Investing Activities:
Payments for patents	0	(980)
Net cash used in investing activities	0	(980)
Cash Flows from Financing Activities:
Proceeds from sale of common stock	69,002	113,650
Note payable related party	(6,500)	9,000
Payments on notes payable	(17,600)	(35,785)
Net cash provided by financing activities	44,902	86,865
Net change in cash	(11,342)	10,326
Cash and Cash Equivalents, at Carrying Value, Beginning Balance	17,583	7,257
Cash and Cash Equivalents, at Carrying Value, Ending Balance	6,241	17,583
Supplemental Disclosure of Cash Flow Information:
Account payable converted to note payable	52,385	52,385
Interest	2,157	6,878
Income taxes	$ 0	$ 0

Items

Items - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Common Stock
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance	$ 267,020	$ 243,920
Shares, Outstanding, Beginning Balance	267,020,268	243,920,268
Stock Issued During Period, Value, Purchase of Assets	$ 11,200	$ 23,100
Stock Issued During Period, Shares, Purchase of Assets	11,200,000	23,100,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	$ 0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance	$ 278,220	$ 267,020
Shares, Outstanding, Ending Balance	278,220,268	267,020,268
Additional Paid-in Capital
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance	$ 7,878,798	$ 7,788,248
Stock Issued During Period, Value, Purchase of Assets	57,802	90,550
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	0	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance	7,936,600	7,878,798
Retained Earnings
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance	(8,350,212)	(8,282,912)
Stock Issued During Period, Value, Purchase of Assets	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(68,302)	(67,300)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance	(8,418,514)	(8,350,212)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance	(204,394)	(250,744)
Stock Issued During Period, Value, Purchase of Assets	69,002	113,650
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(68,302)	(67,300)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance	$ (203,694)	$ (204,394)

Note 1. Nature of Operations

Note 1. Nature of Operations	12 Months Ended
	Dec. 31, 2019
Notes
Note 1. Nature of Operations	Note 1. Nature of Operations Company Overview Stock Exchange Agreement Stock Purchase Agreements Commitments and Contingencies On August 20, 2015, Advanced Voice Recognition Systems, Inc. (“AVRS”) entered into a letter agreement with unrelated third party (Third Party) pursuant to which the Third Party will provide strategic advisory services to AVRS to support the common goal of the acquisition, sale, licensing, prosecution, enforcement, and settlement with respect to AVRS’s intellectual property, including patents held by AVRS. The Third Party has agreed to advance costs recommended by it, including court filing fees, discovery and other litigation costs, and patent prosecution costs, up to an aggregate of $10,000,000. AVRS will be responsible for costs not recommended by the Third Party, as well as travel and ordinary

Note 2. Significant Accounting

Note 2. Significant Accounting Policies	12 Months Ended
	Dec. 31, 2019
Notes
Note 2. Significant Accounting Policies	Going Concern The Company’s current operations are related to patent monetization and filing of additional patents. The Company has entered into a letter agreement with Dominion Harbor Group, LLC to provide strategic advisory services to AVRS. Dominion has agreed to advanced costs up to an aggregate of $10,000,000. On June 28, 2017 the Company and Dominion agreed to terminate the August 20, 2015 Letter Agreement. The Use of Estimates Basis of Consolidation Cash and Cash Equivalents Financial Instruments Fixed Assets Income Taxes Research and Development Costs Patents, Deferred Costs and Amortization Impairment and Disposal of Long-Lived Assets Loss per Common Share Fair Value of Financial Instruments

Note 3. Intangible and Fixed As

Note 3. Intangible and Fixed Assets	12 Months Ended
	Dec. 31, 2019
Notes
Note 3. Intangible and Fixed Assets	Note 3. Intangible Assets Intangible Assets The Company monitors the anticipated outcome of legal actions, and if it determines that the success of the defense of a patent is probable, and so long as the Company believes that the future economic benefit of the patent will be increased, the Company capitalizes external legal costs incurred in the defense of the patent. Upon successful defense of litigation, the amounts previously capitalized are amortized over the remaining life of the patent. On July 7, 2009, U.S. Patent # 7,558,730, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning on July 7, 2009 and ending 20 years from the application date of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2009 and the Company began amortization. On May 24, 2011, U.S. Patent #7,949,534, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning May 24, 2011 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended June 30, 2011 and the Company began amortization. On March 6, 2012, U.S. Patent #8,131,557, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning March 6, 2012 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended March 31, 2012 and the Company began amortization. On July 30, 2013, U.S. Patent #8,498,871, entitled “Dynamic Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning on July 30, 2013 and ending 20 years from the application date of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2013 and the Company began amortization. On June 27, 2013, the Company filed two additional continuation applications 13/928/381 and 13/928,383 with the U.S. Patent and Trademark Office entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols.” On August 31, 2015, Application 13/928,381 was abandoned by the Company. Deferred costs were charged to operations the quarter ended September 30, 2015. SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF FUTURE AMORTIZATION

Note 4. Related Party Transacti

Note 4. Related Party Transactions	12 Months Ended
	Dec. 31, 2019
Notes
Note 4. Related Party Transactions	Note 4. Related Party Transactions Related Parties Transactions and Indebtedness During the years from 2000 through 2013, certain officers advanced the Company working capital to maintain the Company’s operations. The Company owed the officers -0- and $6,500 at December 31, 2019 and 2018 respectively. The Company also owed the officers aggregate of $162,382 at December 31, 2019 and December 31, 2018 for accrued payroll. During the period of year ending December 31, 2019, and December 31, 2018 the Company paid gross payroll of $4,916 and $1,444 to the CEO and for payroll expenses. On September 24, 2018, Walter Geldenhuys, who is our President, Chief Executive Officer and Chief Financial Officer, and who serves as a member of our Board of Directors loaned the Company $9,000. This loan was paid in full December 27, 2019. During the year ending December 31, 2019, AVRS completed Stock Purchase Agreements totaling 11,200,000 shares of AVRS stock to six shareholders. All shares were paid in the period ending December 31, 2019, for a total amount of $69,002. At period ending December 31, 2019 one shareholder owned 8.90% of the issued and outstanding stock.

Note 5. Income Taxes

Note 5. Income Taxes	12 Months Ended
	Dec. 31, 2019
Notes
Note 5. Income Taxes	Note 5. Income Taxes INCOME TAXES

Note 6 . Concentration of Risk

Note 6 . Concentration of Risk	12 Months Ended
	Dec. 31, 2019
Notes
Note 6 . Concentration of Risk	Beginning March 31, 2010, through December 31, 2019, all noninterest-bearing transaction accounts are fully insured, regardless of the balance of $250,000, at all FDIC-insured institutions. On December 31, 2019, the Company had cash balances at one FDIC insured financial institution of $6,241 in non-interest bearing accounts that were fully insured by the FDIC.

Note 7. Note Payable & Accounts

Note 7. Note Payable & Accounts Payable	12 Months Ended
	Dec. 31, 2019
Notes
Note 7. Note Payable & Accounts Payable	On September 24, 2018, Advanced Voice Recognition Systems, Inc., a Nevada corporation (“AVRS”, “we” or “us”), entered into Promissory Note with Walter Geldenhuys, who is our President, Chief Executive Officer and Chief Financial Officer, and who serves as a member of our Board of Directors. The Promissory Note is effective as of September 24, 2018 in the principal amount of $9,000 with a maturity date of the Promissory Note September 24, 2019. Interest at 4% per annum was charged and accrued at December 31, 2018. The Company repaid $2,500 of the note on December 10, 2018. During 2019 the Company repaid $6,500, paying the note in full on December 27, 2019. Interest at 4% per annum was charged and accrued at December 31, 2019.

Note 8. Stockholder Equity _ (D

Note 8. Stockholder Equity / (Deficit)	12 Months Ended
	Dec. 31, 2019
Notes
Note 8. Stockholder Equity / (Deficit)	The Company has issued shares of its common stock pursuant to certain agreements as described in Note 1.

Note 9 . Subsequent Events

Note 9 . Subsequent Events	12 Months Ended
	Dec. 31, 2019
Notes
Note 9 . Subsequent Events	Note 9. Subsequent Events On January 23, 2020 the Company received notice that the Patent, Trial and Appeals Board (“PTAB”) decided to Institute the Inter Partes Review (“IPR”) along with a schedule for the rest of the proceedings. The Company was able to defeat Apple on two out of three of its grounds for Institution. The Company must file a response by April 16, 2020.institution.

Note 2. Significant Accountin_2

Note 2. Significant Accounting Policies: Going Concern (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Going Concern	Going Concern The Company’s current operations are related to patent monetization and filing of additional patents. The Company has entered into a letter agreement with Dominion Harbor Group, LLC to provide strategic advisory services to AVRS. Dominion has agreed to advanced costs up to an aggregate of $10,000,000. On June 28, 2017 the Company and Dominion agreed to terminate the August 20, 2015 Letter Agreement. The Company did not incur any material early termination penalties. In addition the Company has revised the Contingent Fee Agreement with Buether Joe & Carpenter, LLC which will represent AVRS in connection with investigating and asserting claims to the AVRS patents including licensing and litigation activities. Any and all advanced costs will only become liabilities if successful. On June 6, 2017 AVRS and BJC revised the Contingent Fee Agreement as it related to the termination of the August 20, 2015 Dominion Harbor Letter Agreement. There is no guarantee that AVRS will be able to provide the capital required for the Company to continue as a going concern.

Note 2. Significant Accountin_3

Note 2. Significant Accounting Policies: Use of Estimates (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Note 2. Significant Accountin_4

Note 2. Significant Accounting Policies: Basis of Consolidation (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Basis of Consolidation	Basis of Consolidation The consolidated financial statements include our accounts and those of NCC, LLC which merged with and into AVRS, Inc. March 25, 2009. Intercompany transactions and balances have been eliminated. The accounts, results of operations and cash flows of acquired companies are included from their respective acquisition dates.

Note 2. Significant Accountin_5

Note 2. Significant Accounting Policies: Cash and Cash Equivalents (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents. The Company had cash at December 31, 2019 of $6,241 and $17,583 at December 31, 2018. No amounts resulted from cash equivalents.

Note 2. Significant Accountin_6

Note 2. Significant Accounting Policies: Financial Instruments (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Financial Instruments	Financial Instruments The carrying amounts of cash, receivables and current liabilities approximate fair value due to the short-term maturity of the instruments.

Note 2. Significant Accountin_7

Note 2. Significant Accounting Policies: Fixed Assets (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Fixed Assets	Fixed Assets Fixed assets are stated at cost. Depreciation is calculated using the straight-line method over the estimated useful lives of the related assets, ranging from three to five years. Expenditures for additions and improvements are capitalized, while repairs and maintenance costs are expensed as incurred. The cost and related accumulated depreciation of property and equipment sold or otherwise disposed of are removed from the accounts and any gain or loss is recorded in the year of disposal.

Note 2. Significant Accountin_8

Note 2. Significant Accounting Policies: Income Taxes (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Income Taxes	Income Taxes Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the recorded book basis and the tax basis of assets and liabilities for financial and income tax reporting. Deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income and tax credits that are available to offset future federal income taxes. The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material adverse effect on the Company’s financial condition, results of operations, or cash flow. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. The Company did not record a cumulative effect adjustment related to the adoption of ASC 740.

Note 2. Significant Accountin_9

Note 2. Significant Accounting Policies: Research and Development Costs (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Research and Development Costs	Research and Development Costs Research and development costs are expensed in the period incurred.

Note 2. Significant Accounti_10

Note 2. Significant Accounting Policies: Patents, Deferred Costs and Amortization (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Patents, Deferred Costs and Amortization	Patents, Deferred Costs and Amortization Patents consist of costs incurred to acquire issued patents. Amortization commences once a patent is granted. Costs incurred to acquire patents that have not been issued are reported as deferred costs. On April 3, 2018 U.S. Patent #9,934,786 entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols” was issued by the U.S patent and Trademark Office. Deferred costs of $4,575 were capitalized and amortization began in the period. The Company amortizes its patents over an estimated useful life of twenty years.

Note 2. Significant Accounti_11

Note 2. Significant Accounting Policies: Impairment and Disposal of Long-Lived Assets (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Impairment and Disposal of Long-Lived Assets	Impairment and Disposal of Long-Lived Assets The Company evaluates the carrying value of its long-lived assets under the provisions of Statement of Financial Accounting Standard (“SFAS”) No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” now referred to as ASC 360-10 Property, Plant, and Equipment

Note 2. Significant Accounti_12

Note 2. Significant Accounting Policies: Loss per Common Share (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Loss per Common Share	Loss per Common Share The Company reports net loss per share using a dual presentation of basic and diluted loss per share. Basic net loss per share excludes the impact of common stock equivalents. Diluted net loss per share utilizes the average market price per share when applying the treasury stock method in determining common stock equivalents. At December 31, 2019 and 2018, there were no variances between the basic and diluted loss per share as there were no potentially dilutive securities outstanding.

Note 2. Significant Accounti_13

Note 2. Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	12 Months Ended
	Dec. 31, 2019
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Note 3. Intangible and Fixed _2

Note 3. Intangible and Fixed Assets: Schedule of Amortization of Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2019
Tables/Schedules
Schedule of Amortization of Intangible Assets	SCHEDULE OF INTANGIBLE ASSETS Ended December 31, 2018 U.S. Patent # Carrying Value Amortization Balance 7,558,730 58,277 44,574 13,703 7,949,534 3,365 2,426 939 8,131,557 5,092 3,568 1,524 8,498,871 21,114 13,715 7,399 9,142,217 35,068 18,882 16,186 9,934,786 4,575 936 3,639 $ 127,491 $ 84,101 $ 43,390 Amortization at December 31, 2019 is as follows: Ended December 31, 2019 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 49,266 9,011 7,949,534 3,365 2,739 626 8,131,557 5,092 4,090 1,002 8,498,871 21,114 16,247 4,867 9,142,217 35,068 24,278 10,790 9,934,786 4,575 2,184 2,391 $ 127,491 $ 98,804 $ 28,687

Note 3. Intangible and Fixed _3

Note 3. Intangible and Fixed Assets: Schedule of Future Amortization (Tables)	12 Months Ended
	Dec. 31, 2019
Tables/Schedules
Schedule of Future Amortization	SCHEDULE OF FUTURE AMORTIZATION

Note 5. Income Taxes_ Income Ta

Note 5. Income Taxes: Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2019
Tables/Schedules
Income Taxes	INCOME TAXES December 31, 2019 December 31, 2018 U.S. federal statutory graduated rate 21.00 % 21.00 % State income tax rate, net of federal benefit 0.00 % 0.00 % Contributed services 00.00 % 00.00 % Costs capitalized under Section 195 -21.00 % -21.00 % Effective rate 0.00 % 0.00 %

Note 2. Significant Accounti_14

Note 2. Significant Accounting Policies: Going Concern (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Details
Total Stockholders' Deficit	$ (203,694)	$ (204,394)
Proceeds from sale of common stock	$ 69,002	$ 113,650

Note 2. Significant Accounti_15

Note 2. Significant Accounting Policies: Cash and Cash Equivalents (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Details
Total Current Assets	$ 6,241	$ 17,583	$ 7,257

Note 3. Intangible and Fixed _4

Note 3. Intangible and Fixed Assets: Schedule of Amortization of Intangible Assets (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
U.S. Patent # 7,558,730
Carrying Value	$ 58,277	$ 58,277
Amortization	49,266	44,574
Balance	9,011	13,703
U.S. Patent # 7,949,534
Carrying Value	3,365	3,365
Amortization	2,739	2,426
Balance	626	939
U.S. Patent # 8,131,557
Carrying Value	5,092	5,092
Amortization	4,090	3,568
Balance	1,002	1,524
U.S. Patent # 8,498,871
Carrying Value	21,114	21,114
Amortization	16,247	13,715
Balance	4,867	7,399
U.S. Patent # 9,142,217
Carrying Value	35,068	35,068
Amortization	24,278	18,882
Balance	10,790	16,186
U.S. Patent # 9,934,786
Carrying Value	4,575	4,575
Amortization	2,184	936
Balance	$ 2,391	$ 3,639

Note 3. Intangible and Fixed _5

Note 3. Intangible and Fixed Assets: Schedule of Future Amortization (Details)	Dec. 31, 2019USD ($)
Details
2020	$ 14,702
2021	13,985
Balance	$ 28,687

Note 4. Related Party Transac_2

Note 4. Related Party Transactions (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Details
Notes Payable, Current	$ 0	$ 6,500
Payroll	162,382	162,382
Compensation	4,916	1,444
Proceeds from sale of common stock	$ 69,002	$ 113,650

Note 5. Income Taxes_ Income _2

Note 5. Income Taxes: Income Taxes (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Details
U.S. federal statutory graduated rate	21.00%	21.00%
State income tax rate, net of federal benefit	0.00%	0.00%
Contributed services	0.00%	0.00%
Costs capitalized under Section 195	(21.00%)	(21.00%)
Effective rate	0.00%	0.00%

Note 6 . Concentration of Risk

Note 6 . Concentration of Risk (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Details
Total Current Assets	$ 6,241	$ 17,583	$ 7,257